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Abstract
Genome-wide interaction-based association (GWIBA) analysis has the potential to identify novel susceptibility loci. These
interaction effects could be missed with the prevailing approaches in genome-wide association studies (GWAS). However,
no convincing loci have been discovered exclusively from GWIBA methods, and the intensive computation involved is a
major barrier for application. Here, we developed a fast, multi-thread/parallel program named ‘‘pair-wise interaction-based
association mapping’’ (PIAM) for exhaustive two-locus searches. With this program, we performed a complete GWIBA
analysis on seven diseases with stringent control for false positives, and we validated the results for three of these diseases.
We identified one pair-wise interaction between a previously identified locus, C1orf106, and one new locus, TEC, that was
specific for Crohn’s disease, with a Bonferroni corrected P,0.05 (P=0.039). This interaction was replicated with a pair of
proxy linked loci (P=0.013) on an independent dataset. Five other interactions had corrected P,0.5. We identified the allelic
effect of a locus close to SLC7A13 for coronary artery disease. This was replicated with a linked locus on an independent
dataset (P=1.09610
27). Through a local validation analysis that evaluated association signals, rather than locus-based
associations, we found that several other regions showed association/interaction signals with nominal P,0.05. In
conclusion, this study demonstrated that the GWIBA approach was successful for identifying novel loci, and the results
provide new insights into the genetic architecture of common diseases. In addition, our PIAM program was capable of
handling very large GWAS datasets that are likely to be produced in the future.
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Introduction
Recent genome-wide association studies (GWAS) have identified
many common genetic variants associated with common diseases.
This has rapidly expanded our knowledge of the genetic
architecture of these diseases. For example, the Wellcome Trust
Case Control Consortium (WTCCC) study [1] and other large-
scale GWASs (including meta-analyses) have discovered many
susceptibility loci for common diseases, including coronary artery
disease(CAD)[2],Crohn’s disease (CD)[3,4],type1diabetes(T1D)
[5], and type 2 diabetes (T2D) [6]. However, compared with the
successes of single-locus approaches, the achievements of interac-
tion-based approaches, which seek susceptibilities that derive from
gene-gene interactions, have lagged behind [7,8]. Thus, gene-gene
interactions that are largely undetected may explain some of the
heritability of common diseases [9]. Most reported interactions are
currently found through candidate approaches, which incorporate
prior biological knowledge. Moreover, very few interactions have
been confirmed in an independent population.
Genome-wide interaction-based association (GWIBA) analysis
uses markers to conduct genome-wide screens without prior
candidate selection. In addition, GWIBA incorporates interaction
effects among genetic variants. Many interaction-based methods
for GWIBA are currently available, including a logistic regression-
based method [10]; in addition, several methods have been
recently developed [11–15]. However, no studies on real data have
successfully identified novel disease-associated loci. Two studies
reported non-significant results on small datasets [11,14]; several
studies with the WTCCC dataset reported problematic interac-
tions [12,13,15], and those were found to be probable false
positives in this study. Thus, the GWIBA methods have identified
very few new loci convincingly, and none of the detected
interactions have been replicated to date. In addition, the
computational time was a major barrier for GWIBA analyses on
large-scale GWAS datasets. Most previous studies resorted to
stochastic searches, or partial search strategies based on biological
knowledge [12–18]. Until recently, genome-wide association
studies have followed the traditional single-locus approach and
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approaches.
In this study, our main aim was to discover novel susceptibility
loci by identifying interaction effects in a GWIBA analysis with the
large-scale WTCCC dataset [1]. We also aimed to confirm these
novel loci in independent datasets. To that end, we identified
several novel susceptibility loci with replication/validation evi-
dence, and the results provide new insights into the genetic
architecture of common diseases.
Results
Identification of Gene Interactions
We performed a complete GWIBA analysis with validation
analyses. We started with the WTCCC dataset [1], which
contained ,2,000 cases for seven diseases and ,3,000 shared
controls (Materials and Methods). The quality-controlled
WTCCC data were used as input for the ‘‘pair-wise interaction-
based association mapping’’ (PIAM) program, and we performed
an exhaustive two-locus search for each disease (Materials and
Methods). We used the single-locus likelihood ratio test (LRT) p-
value (5610
27) as a cutoff value for incorporating the single-locus
effects in the PIAM searches. The cutoff value was based on the
significance threshold set by WTCCC for single-locus analyses.
This prevented the marginal effects of a few loci from dominating
the interactions. The computation was performed with the PIAM
program running in parallel on computer clusters.
In the initial search, we used the cases and the shared controls of
the WTCCC data to screen single-nucleotide polymorphism (SNP)
pairs that passed a p-value threshold of P,50/L, where L was the
total number of two-locus combinations for each disease. The
threshold allowed SNP pairs with p-values that were 1,000 times
larger than the significance level of 0.05/L. During the calculation,
the distributions of two-locus statistics were evaluated with the
approximate statistical distribution method in PIAM (Materials
and Methods), which generated genome-wide two-locus quantile-
quantile plots (Figure S1). We obtained 2,570 SNP pairs for seven
diseases at these screening thresholds (Table S1A), after excluding
20,968 SNP pairs within the major histocompatability complex
(MHC) region for rheumatoid arthritis (RA) and T1D (Table S1B).
Although many SNP pairs had rather significant p-values, there
were an overwhelming number of false positive results observed.
We found that the initial SNP quality control performed by the
WTCCC was not sufficiently stringent for the interaction searches,
due to sparse data and poor genotyping quality. The sparseness of
the data was due to the constraint that we used two-locus genotype
interaction analyses, instead of the single-locus analysis applied by
the WTCCC; this relative sparseness of data conferred a higher
sensitivity to genotyping errors. Therefore, a stringent additional
SNP quality control was applied (Materials and Methods). A total
of 1,392 SNP pairs passed this additional quality control (Table
S1C).
After the initial search, these 1,392 SNP pairs were tested with
the expanded controls to gain greater statistical power (Materials
and Methods). We retained 634 SNP pairs that gave Bonferroni
corrected P,0.5 (Table S1D), according to the numbers of
available two-locus tests (Table S2).
Among the results from the 634 SNP pairs, we observed two
major types of problematic results, irrespective of the SNP quality
control. The first problem was that we found many ‘‘interactions’’
between known susceptibility loci with large marginal effects.
These ‘‘interactions’’ might have resulted from marginal effects,
according to the two-locus LRT tests that incorporated both
marginal and pure interaction effects. To control for this problem,
we used a strategy similar to BEAM [19], where we compared the
two-locus p-values with the single-locus p-values. The second
problem was that we found 88 SNP pairs with linked SNPs (Table
S1E); most of these gave quite significant p-values, but were
identified as artificial associations that could be separated into two
types, one was a batch effect and the other was a genotype
clustering problem. These artificial associations were due to sparse
data and genotyping artifacts. Later, we found that some
previously reported interactions were probably these kinds of
artificial associations [12,13,15] (details in Discussion). Therefore,
a stringent result filter was applied to filter out these false positive
interactions (Materials and Methods). Thus, we removed 536 SNP
pairs with excessive marginal effects, and 85 SNP pairs with the
two kinds of artificial associations. Within the 88 SNPs pairs with
linked SNPs, 3 pairs were not affected by artificial associations;
therefore, these interactions were considered true haplotypic
associations. These 3 SNP pairs were located in regions known
to be associated with CD, thus, we did not present these results in
detail here, except in the corresponding regional signal plots
(Figure S2) and odds ratio (OR) tables (Table S3). Finally, 10 SNP
pairs with unlinked SNPs remained qualified (Table S1F).
After the result filtering, the simultaneous searches identified an
interaction between rs7522462 (on C1orf106) and rs11945978 (on
TEC) for CD with a Bonferroni corrected P,0.05, and another
five pairs of regions associated with CAD, CD, T1D, and T2D
with Bonferroni corrected P,0.5 (Table 1; Figure 1). Among the
above six pairs of regions, the interaction between rs7522462 and
rs11945978 for CD, and the allelic effect of rs6470733 (close to
SLC7A13) for CAD were replicated by proxy linked SNPs. In
addition, we validated one pair of interacting regions around
rs153423 (near SPRY4) and rs748855 (on NOD2) for CD, one
single region around rs1501540, and one pair of interacting
regions around rs11731175 and rs11236365 (on SLCO2B1) for
T2D, all with nominal P,0.05, through local validation analyses
(Materials and Methods; Table 1; Figure 2). We then performed
Author Summary
Recent studies on the genetic basis of common diseases
have identified many loci that confer disease susceptibility.
However, much of the heritability of these diseases
remains unexplained. Loci involved in gene–gene interac-
tions are considered cryptic, because they confer suscep-
tibility, but may not generate a detectable signal on their
own. These interactions may account for the ‘‘missing
heritability’’ of common diseases. Theoretically, these
interactions can be identified with the genome-wide
interaction-based association analysis. But, in reality, very
few gene–gene interactions have been identified with that
method, and most were based on prior biological
knowledge. Here, we applied a parallel computing
technique that facilitated the identification of multiple
new cryptic susceptibility loci involved in common
diseases. We applied stringent control for false positives,
and we validated our findings with independent datasets.
This study demonstrated that interactions between gene
loci could be successfully identified with the genome-wide
interaction-based approach. With this approach, we also
identified cryptic loci with moderate single-locus effects.
The identified loci and interactions merit further investi-
gations for fine mapping and functional analyses. Our
results extend the current knowledge of common diseases
for future studies in genetic mapping. This approach is
applicable to current and future genome-wide association
datasets.
Genome-Wide Interaction-Based Association Analysis
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listed in Table 1; this did not produce any significant results.
We did not identify any interactions for bipolar disorder (BD),
hypertension (HT), or RA, according to the significance thresholds
and result filtering applied (except the interactions within the
MHC region for RA). In fact, a single-locus analysis did not
identify significant results for HT, and only one significant locus
was associated with BD, but this has not been replicated to date
[1,20]. This may indicate that the quality control and result
filtering we performed was effective for removing random false
positives and artificial associations.
Within each SNP pair in Table 1, the SNPs were independent
in the controls and dependent in the cases (Table 2). The SNPs in
Table 1 showed good genotype clustering (Figure S3), and did not
present any significant deviations from Hardy-Weinberg equilib-
rium (HWE, P.0.05). Note that the corrected two-locus p-values
in Table 1 were only corrected within each disease.
CAD
Only one pair of interacting loci was associated with CAD. The
SNPs were rs9397512 and rs6470733, located at the intron of
SYNE1 and 7 kb downstream from SLC7A13, respectively. Note
that this interaction only gave a moderate corrected p-value of
0.380. However, this pair of regions generated wide, block-like
interaction signals (Figure 1), with strong linkage disequilibrium
(LD) (Figure S4, plotted with Haploview [21]). For this interaction,
when the rs6470733 genotypes were paired with the TT genotype
stratum of rs9397512, the effects were in the opposite direction
compared to those observed when the rs6470733 genotypes were
paired with the CC and CT strata (Table 3). The highest OR
relative to the most common homozygote combination (2.95) was
higher than the OR under the assumption of an additive effect of
the two loci (1.95). The two loci also showed moderate single-locus
allelic effects, especially rs6470733.
In order to validate the association of the two loci identified for
CAD, we used the online results of the German MI Family Study
(GerMIFS) [2], which included 875 cases and 1644 controls
(Materials and Methods). Surprisingly, we found that rs13262822,
which was 1.5 kb downstream from rs6470733 and had an
r
2=0.90 (based on the WTCCC shared controls), showed a rather
significant allelic effect with a trend test P=1.09610
27 (Table 4).
In addition, rs13262822 showed an allelic effect in the WTCCC
data with a trend test P=1.81610
23 and an association in the
same direction. Therefore, the allelic effect of the original SNP,
rs6470733, was replicated by its proxy SNP rs13262822, in strong
LD. Interestingly, in the GerMIFS data, the minor allele
frequency (MAF) of rs13262822 was a bit larger than that in the
WTCCC data, and the OR of 1.39 was much higher compared to
the OR of 1.16 reported in the WTCCC. The previous paper did
not identify the rs13262822 locus because the trend p-value of
rs13262822 in the WTCCC data marginally failed the 0.001
threshold before the combined analysis [2]. At this time, the online
result from the GerMIFS data is not sufficient to confirm the
marginal effect of rs9397512 or the interaction effect. SYNE1 was
previously suggested as a potential mediator of cardiomyopathy,
because it showed muscle-specific inner nuclear envelope expre-
ssion and a physical interaction with lamin A/C [22]. Further-
more, a recent study suggested that SYNE1 was involved in the
pathogenesis of Emery Dreifuss muscular dystrophy through
skeletal muscle cell destruction [23], which emphasized the
functional role of SYNE1 in muscles. SLC7A13 is a cationic amino
acid transporter, and two early studies showed that cationic amino
Table 1. Identified gene interactions.
Disease SNP Chr
Nearest
Gene
Trend
p-value
Validation of
allelic effect
Pure
interaction
p-value
Validation of
interaction
Two-locus
p-value
(expanded)
Test
numbers
Corrected
p-value
(expanded)
CAD rs9397512 6q25.2 SYNE1 5.68610
23 Unavailable 1.54610
28 Unavailable 8.82610
212 4.31610
10 0.380
rs6470733 8q21.3 SLC7A13 9.18610
24 PPR=1.09610
27
CD rs7522462 1q32.1 C1orf106 2.36610
25 Meta-analysis 5.03610
26 PPR=0.013 8.90610
213 4.33610
10 0.039
*
rs11945978 4p12 TEC 0.016 PPR=0.047
CD rs153423 5q31.3 SPRY4 3.21610
23 Not significant 4.28610
25 PLV=0.034 3.36610
212 4.33610
10 0.146
rs748855 16q12.1 NOD2 2.63610
27 Known region
T1D rs7310460 12p13.31 CLEC2D 9.43610
24 Meta-analysis 1.09610
28 Unavailable 5.87610
212 4.29610
10 0.252
rs2302270 12q24.32 - 0.673 -
T2D rs1501540 1p34.3 - 2.24610
24 PLV=0.022 2.13610
27 Not significant 1.92610
212 4.26610
10 0.082
rs7359782 18p11.21 C18orf58 4.51610
23 Not significant
T2D rs11731175 4q35.2 - 0.115 - 1.68610
211 PLV=0.029 7.00610
212 4.26610
10 0.298
rs11236365 11q13.4 SLCO2B1 0.715 -
Six pairs of SNPs that represented interacting loci. Chr: chromosome and cytoband information. Nearest Gene: When the nearest annotated gene was .500 kb away
from the SNPs, it was not listed. The trend p-values were obtained with the shared controls. The validation of allelic effect for loci with original trend p-values.0.05 is
not presented. Validation status: Unavailable, data unavailable for validation; PPR, p-value of the proxy replication; Meta-analysis, susceptibility locus found by meta-
analysis studies after the WTCCC study; Not significant, validation was not significant (P.0.05); Known region, a susceptibility region that was known at the time of the
WTCCC study; PLV, p-value of the local validation. The last five columns contain the interaction results. Pure interaction p-values were obtained with the shared controls.
Two-locus p-value (expanded): two-locus LRT p-value according to the search situation, and the two-locus p-values and the corresponding corrected p-values for the
final significance were obtained in the expanded control analysis.
*Bonferroni corrected P,0.05. Because all of these loci were obtained in the simultaneous searches, in which the two-locus tests took account of all effects of
the two loci, therefore the main effects and the interaction effects were examined in the validation analyses, and the following criterion was used to determine the
validation status of each locus: (1) if the pure interaction effect was validated (i.e. P,0.05), both of the loci and their interaction effect were validated, irrespective of the
validations of the main effects; (2) if the pure interaction effect was not validated, then the validation status of a locus was determined by the validation of its main
effect.
doi:10.1371/journal.pgen.1001338.t001
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formation by regulating L-ornithine transport and polyamine
synthesis in vascular smooth muscle [24,25]. Thus, these two genes
may be involved in different, but related aspects of CAD
pathogenesis. This could explain the statistical interaction between
the two regions.
CD
Two pairs of interacting loci were associated with CD. The first
interaction was between rs7522462, which is in the region of
C1orf106 gene, and rs11945978, which is in a newly identified
region of the TEC gene. The C1orf106 region was previously
identified in a meta-analysis after the WTCCC study, which
Figure 1. Regional signal plots of the interactions in Table 1 with WTCCC data. SNPs within 100 kb of the most significant SNP pairs are
shown. For each panel, the upper left plot is the color key for the interaction signal plot at the lower right; the lower left and upper right plots are
single-locus signal plots with gene annotations. These plots are aligned by chromosome positions in Mb, which are based on NCBI build 36. The red
dotted lines and the red dot in the middle indicate the position of the most significant pair of SNPs in the corresponding regions. The solid black dots
in the single-locus signal plots denote the trend test p-values (values indicated by the numbered axes) and the colored images in the interaction
signal plots denote the pure interaction p-values (values indicated by the color key in the upper left box); these were obtained with the shared
controls and transformed by a negative logarithm.
doi:10.1371/journal.pgen.1001338.g001
Figure 2. Regional signal plots of the interactions observed in validation datasets. The signal plots of three interactions for CD and two
interactions for T2D are shown. The interactions were observed in the IBDGC non-Jewish population data and the GENEVA Diabetes Study data,
respectively. The format of this figure is similar to that described in Figure 1; the red dotted lines and the red dot in the middle indicate the positions
of the originally identified SNP pair. Two other red dotted lines for each single-locus signal plot and the red box in the interaction signal plot were
added to indicate the regions used for the local validation tests; the blue dotted lines indicate the p-value thresholds of 0.05. (The interaction
between rs7522462 and rs11945978 was replicated by proxy SNPs; therefore, its local validation was disregarded).
doi:10.1371/journal.pgen.1001338.g002
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institute of diabetes, digestive, and kidney diseases (NIDDK)
inflammatory bowel disease genetics consortium (IBDGC) [4].
This interaction gave a Bonferroni corrected P=0.039. The
interaction signal showed a clear block that extended over several
tens of kb (Figure 1). In the IBDGC data, a weak interaction signal
also appeared at the corresponding regions (Figure 2). For this
interaction, the single-locus effect of rs7522462 varied significantly
among the genotype strata of rs11945978, which indicated the
interaction (Table 3), and the effect of rs7522462 was strongest in
the rs11945978 CC stratum.
Validation analysis with the IBDGC data supported the
interaction between rs7522462 and rs11945978 (Materials and
Methods). We selected proxy SNPs in the IBDGC data instead of
the original SNPs, according to HapMap [26] CEU r
2 values. For
rs7522462, two proxy SNPs were in moderate LD: rs296533,
which is 16 kb upstream, with an r
2=0.44, and rs296547, which is
10 kb downstream, with an r
2=0.79. For rs11945978, the proxy
SNP rs2089509 showed perfect linkage disequilibrium (LD) in the
HapMap CEU population. The allelic effects, interaction effect,
and combined effect of the proxy SNP combination of rs296533
and rs2089509 were replicated in the IBDGC non-Jewish
population data (rs296533 trend P=0.020, rs2089509 trend
P=0.047, pure interaction P=0.013, two-locus P=0.001). The
ORs showed trends similar to those in the WTCCC data,
particularly in the CC genotype stratum of rs11945978 (corre-
sponding to the GG genotype stratum of rs2089509) (Table 5).
The trend P of rs7522462 stratified by rs11945978 CC, and the
trend P of rs296533 stratified by rs2089509 GG were 2.05610
28
and 1.35610
23, respectively. The risk alleles of rs7522462 and its
proxy, rs296533, and the risk alleles of rs11945978 and its proxy,
rs2089509, comprised the major haplotypes according to the
HapMap data. This indicated the same association direction in the
WTCCC data and the IBDGC non-Jewish population data.
Although the interaction between rs296533 and rs2089509 was
not significant in the IBDGC Jewish population data (with quite a
small sample size), the interaction showed a similar pattern (Table
S4). Nevertheless, the downstream proxy SNP, rs296547, had a
larger r
2 value of 0.79 and the interaction was not significant in the
IBDGC data. This may be explained by the small sample size and
the LD difference between the HapMap data and the IBDGC
data for the marker loci and the causing loci. For SNPs that were
either ungenotyped in the WTCCC or in the IBDGC non-Jewish
population data (rs7522462, rs11945978, rs296533, rs2089509),
the corresponding genotypes were imputed (Materials and
Methods). We found a consistent interaction between rs296533
and rs2089509, which was significant in both the IBDGC non-
Jewish population data (P=0.013) and the imputed WTCCC data
(P=0.015), and they showed a similar interaction pattern (Table
S4). A previous study found that the expression of TEC was up-
regulated upon T-cell activation, and Tec overexpression in
lymphocyte cell lines was sufficient to induce phosphorylation of
phospholipase C gamma and activation of nuclear factor of
activated T cells [27]; moreover, over-activation of T cells is a
typical feature of CD.
The second interaction for CD was between rs153423 and
rs748855, which gave a corrected P of 0.146. The latter SNP lies
in the early identified NOD2 gene [1]; the former SNP is located
about 100 kb upstream from the SPRY4 gene, and the association
signal extended fairly close to the gene (Figure 1). The two-locus
pattern showed that rs153423 was epistatic to rs748855, because
the most common rs153423 genotype (AA) masked a considerable
single-locus effect of rs748855 (Table 3). Locus-based replication
for this interaction failed, and local validation of the interaction
with the IBDGC non-Jewish population data indicated a
nominally significant interaction (P=0.034; Figure 2). A previous
study showed that SPRY4 suppressed vascular epithelial growth
factor-induced, Ras-independent activation of Raf1 [28]; more-
over, another study suggested that vascular epithelial growth
factor-A signaling was related to CD through angiogenesis [29].
T1D
Only one pair of interacting loci was associated with T1D. The
SNPs, rs7310460 and rs2302270, interacted with a moderate
corrected P of 0.252. The 12p13.31 region around rs7310460 was
previously found in a meta-analysis study conducted after the
WTCCC study [5]. This region harbors many immunoregulatory
genes, including CLEC2D. In contrast, rs2302270 is mapped to an
intergenic region. The association signal for the interaction effect
extended about 100 kb for both regions with clear borders, and it
included the previously suggested CD69 gene [5] (Figure 1). The
association pattern showed that rs2302270 was epistatic to
rs7310460 (Table 3). We currently have no available data to
validate the association of the rs2302270 region or the interaction.
T2D
Two pairs of interacting loci were associated with T2D. The
first interaction was between rs1501540 and rs7359782, which
gave a corrected P of 0.082. The rs1501540 SNP is mapped to a
region with no annotated genes, and rs7359782 is located 238 kb
upstream of C18orf58. The interaction signal was very narrow;
however it was not restricted to a single SNP (Figure 1). The
Table 2. Tests for SNP independence in the interactions observed in the case and control groups.
Simulation 1 P Simulation 2 P Simulation 3 P
Disease Interaction Case Control Case Control Case Control
CAD rs9397512, rs6470733 0.0015 0.3224 0.0015 0.3288 0.0015 0.3314
CD rs7522462, rs11945978 0.0027 0.0577 0.0022 0.0588 0.0022 0.0568
CD rs153423, rs748855 0.0273 0.2240 0.0283 0.2300 0.0267 0.2271
T1D rs7310460, rs2302270 0.0020 0.1675 0.0033 0.1633 0.0021 0.1613
T2D rs1501540, rs7359782 0.0021 0.5032 0.0025 0.4957 0.0022 0.5002
T2D rs11731175, rs11236365 0.0020 0.1453 0.0023 0.1480 0.0020 0.1492
Each row represents one gene-gene interaction listed in Table 1. Chi-square tests of 3 by 3 contingency tables were used to determine whether two SNPs were
dependent in the case group or in the control group. For each test, 10,000 Monte Carlo simulations were used to obtain the p-value; each test was repeated 3 times for
both the case group and the control group. The tests were performed with the R statistical software (http://www.r-project.org/).
doi:10.1371/journal.pgen.1001338.t002
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Study
Minor/risk
allele
CC/CG/GG
counts in case
CC/CG/GG
counts in control
Case/control
frequency of
minor allele Trend P OR (95% CI)
WTCCC C/C 183/752/986 195/1148/1593 0.362/0.326 1.81610
23 1.16 (1.06,1.27)
GerMIFS C/C 58/448/229 144/683/745 0.552/0.395 1.09610
27 1.39 (1.22,1.59)
OR (95%CI): Odds ratios with 95% confidence intervals.
doi:10.1371/journal.pgen.1001338.t004
Table 3. OR tables for the SNP pairs shown in Table 1.
CAD rs6470733 CD rs11945978
rs9397512 AA AG GG rs7522462 CC CT TT
OR CC 1 1.52 (1.24,1.87) 1.52 (1.05,2.20) OR GG 1 0.64 (0.54,0.76) 0.97 (0.75,1.27)
CT 1.33 (1.10,1.60) 1.21 (0.99,1.47) 2.95 (2.16,4.02) GA 0.77 (0.64,0.92) 0.64 (0.53,0.77) 0.64 (0.47,0.86)
TT 1.81 (1.43,2.28) 1.43 (1.10,1.86) 0.87 (0.49,1.54) AA 0.32 (0.22,0.48) 0.78 (0.56,1.08) 0.44 (0.23,0.81)
OR1 CC 1 1.52 (1.24,1.87) 1.52 (1.05,2.20) OR1 GG 1 0.64 (0.54,0.76) 0.97 (0.75,1.27)
CT 1 0.91 (0.76,1.09) 2.22 (1.65,3.00) GA 1 0.83 (0.68,1.02) 0.83 (0.61,1.13)
TT 1 0.79 (0.59,1.06) 0.48 (0.27,0.86) AA 1 2.43 (1.49,3.96) 1.36 (0.66,2.79)
OR2 CC 1 1 1 OR2 GG 1 1 1
CT 1.33 (1.10,1.60) 0.80 (0.65,0.97) 1.94 (1.25,3.01) GA 0.77 (0.64,0.92) 1.00 (0.82,1.22) 0.65 (0.45,0.94)
TT 1.81 (1.43,2.28) 0.94 (0.72,1.23) 0.57 (0.30,1.10) AA 0.32 (0.22,0.48) 1.22 (0.88,1.70) 0.45 (0.23,0.86)
CD rs748855 T1D rs2302270
rs153423 AA AG GG rs7310460 GG GA AA
OR AA 1 0.97 (0.83,1.14) 0.71 (0.57,0.90) OR TT 1 0.62 (0.48,0.79) 0.62 (0.30,1.31)
AG 1.76 (1.43,2.16) 1.08 (0.88,1.31) 0.70 (0.51,0.97) TA 1.12 (0.96,1.32) 1.27 (1.04,1.53) 0.82 (0.48,1.41)
GG 1.14 (0.69,1.90) 0.29 (0.12,0.70) 1.39 (0.66,2.92) AA 0.89 (0.72,1.10) 1.59 (1.22,2.09) 3.79 (1.56,9.21)
OR1 AA 1 0.97 (0.83,1.14) 0.71 (0.57,0.90) OR1 TT 1 0.62 (0.48,0.79) 0.62 (0.30,1.31)
AG 1 0.61 (0.48,0.78) 0.40 (0.28,0.56) TA 1 1.13 (0.94,1.34) 0.73 (0.43,1.25)
GG 1 0.26 (0.10,0.70) 1.22 (0.50,2.95) AA 1 1.79 (1.33,2.39) 4.24 (1.73,10.4)
OR2 AA 1 1 1 OR2 TT 1 1 1
AG 1.76 (1.43,2.16) 1.11 (0.91,1.34) 0.98 (0.68,1.41) TA 1.12 (0.96,1.32) 2.05 (1.58,2.65) 1.31 (0.53,3.24)
GG 1.14 (0.69,1.90) 0.30 (0.13,0.72) 1.95 (0.91,4.17) AA 0.89 (0.72,1.10) 2.58 (1.87,3.55) 6.07 (1.93,19.1)
T2D rs7359782 T2D rs11236365
rs1501540 CC CT TT rs11731175 TT TC CC
OR GG 1 0.92 (0.75,1.13) 1.27 (0.90,1.79) OR GG 1 1.23 (1.02,1.46) 1.06 (0.69,1.63)
GA 0.97 (0.81,1.16) 0.82 (0.68,1.00) 0.59 (0.42,0.84) GT 1.14 (0.98,1.32) 1.28 (1.06,1.55) 0.89 (0.54,1.48)
AA 0.79 (0.62,1.00) 0.73 (0.56,0.96) 0.03 (0.00,0.21) TT 1.83 (1.43,2.35) 0.33 (0.20,0.56) 0.19 (0.02,1.51)
OR1 GG 1 0.92 (0.75,1.13) 1.27 (0.90,1.79) OR1 GG 1 1.23 (1.02,1.46) 1.06 (0.69,1.63)
GA 1 0.85 (0.71,1.01) 0.61 (0.43,0.86) GT 1 1.13 (0.93,1.37) 0.79 (0.47,1.30)
AA 1 0.93 (0.69,1.26) 0.04 (0.01,0.27) TT 1 0.18 (0.10,0.32) 0.10 (0.01,0.83)
OR2 GG 1 1 1 OR2 GG 1 1 1
GA 0.97 (0.81,1.16) 0.90 (0.73,1.10) 0.46 (0.29,0.73) GT 1.14 (0.98,1.32) 1.05 (0.85,1.30) 0.84 (0.44,1.60)
AA 0.79 (0.62,1.00) 0.80 (0.60,1.06) 0.02 (0.00,0.17) TT 1.83 (1.43,2.35) 0.27 (0.16,0.46) 0.18 (0.02,1.47)
This table facilitates the interpretation of the statistical interactions. The statistics were obtained with the shared controls. For each SNP pair, there are three odds ratio
tables: the OR, OR1, and OR2. Each OR table has 9 odds ratio values for 9 genotype combinations. 95% confidence intervals are shown in parentheses. OR: odds ratios of
the two-locus genotype combinations, relative to the most common homozygote combination. OR1 and OR2: odds ratios of one of the two SNPs, where the samples
were stratified by the genotypes of the other SNP; the interaction is indicated by different odds ratio values of one SNP between different genotype strata of the other
SNP.
doi:10.1371/journal.pgen.1001338.t003
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validation analysis. However, the region around rs1501540
showed large allelic effects and was validated in the GENEVA
Diabetes Study data with the local validation strategy (P=0.022;
Figure 2). In contrast, we did not detect any SNPs that were both
significant and in the same direction in the two populations.
Interestingly, we found that the significant SNPs in each dataset
showed different frequencies between the two populations
(MAF=0.27 in the WTCCC data, MAF=0.14 in the GENEVA
data, with respect to the most significant SNPs in the associated
region of each dataset, rs1501540 and rs302001); but, within each
population, the significant SNPs showed similar frequencies.
The second interaction for T2D was between rs11731175 and
rs11236365, which gave a corrected two-locus P of 0.298. Neither
of the SNPs showed obvious marginal effect (trend P and
genotypic LRT test P.0.05). The rs11731175 SNP lies within a
region where the nearest annotated gene is more than 500 kb
away, and rs11236365 is mapped to the SLCO2B1 gene (Figure 1).
The association pattern clearly showed that rs11731175 was
epistatic to rs11236365. The GG and GT genotypes of
rs11731175 masked the effect of rs11236365 (Table 3). However,
when the genotype of rs11731175 was TT, rs11236365 showed a
very strong effect. Moreover, the ORs of the TT and CT
genotypes of rs11236365 relative to the most common homozy-
gote combination were 1.83 and 0.33, respectively. It appeared
that the C allele of rs11236365 provided a strong protective effect
against T2D. The exact replication of this interaction with the
GENEVA Diabetes Study data was not significant. Local
validation of the interaction was nominally significant
(P=0.029), and the interaction signal was very close to the
original signal (Figure 2). SLCO2B1 is an organic anion
transporting polypeptide, and one of its substrates, dehydroepian-
drosterone-sulfate (DHEA-S, a direct metabolite of DHEA) [30],
was found in several early studies to increase insulin sensitivity in a
T2D mouse model [31,32], in rats [33–35], and in humans [36].
Discussion
Recent studies on the genetics of common diseases have
revealed a lot of susceptibility loci and produced many tools for
data analyses. However, the GWIBA approaches, which are
prospective methods for discovering novel interacting loci, had not
succeeded in identifying convincing interactions. In the present
study, we developed an effective GWIBA approach that facilitated
the discovery of novel loci. First, we used the parallel search
program, PIAM, and implemented a simple statistical method and
an optimized algorithm for detecting interactions. This could
complete two-locus exhaustive searches on large-scale GWAS data
in a short time. Second, in addition to the initial search, we used
expanded controls with large sample sizes to gain statistical power
for detecting interactions. Third, the results were carefully
examined, and we found the artificial associations as well as the
‘‘interactions’’ with excessive single-locus effects. Finally, we
employed independent datasets to validate the detected interac-
tions; moreover, we introduced the ‘‘local validation’’ method for
the validation of interactions between populations, where
confounding factors may affect the consistency of the observed
interactions.
Implications for the Genetic Architecture of Common
Diseases
In Table 1, two regions were previously identified through
meta-analysis studies. One region associated with CD, the
C1orf106, which did not achieve significance in the WTCCC
study, was subsequently identified in a meta-analysis study that
included the WTCCC data and the IBDGC data [4]. We
identified this region by including only the WTCCC data that
showed corrected p-values,0.05. Also, the region on 12p13.31
that was associated with T1D was previously identified in a meta-
analysis study of T1D [5]. These results demonstrated that this
GWIBA approach enhanced the power of detecting loci with
moderate single-locus effects; it also implied that some known
susceptibility loci with moderate single-locus effects might be
interacting with other loci. Moreover, we reasoned that interaction
effects could increase the overall effects of loci that only showed
marginal effects, and there were very few examples of large-effect
common variants for common diseases [9]; therefore, we
speculated that interactions of common variants may prefer to
reside on loci with moderate to small single-locus effects. This
hypothesis could explain a common phenomenon that there was
seldom any significant interaction detected by the means of
investigating interactions among loci with certain marginal effects
after the single-locus analyses [1,4,5,8].
Our exhaustive searches revealed several two-locus associations,
where both the individual loci exhibited relatively small single-
locus effects. The most extreme case was the interaction between
Table 5. Comparison of OR tables between two datasets for one CD interaction.
CD (WTCCC) rs11945978 CD (IBDGC) rs2089509
rs7522462 CC CT TT rs296533 GG GA AA
OR GG 1 0.64 (0.54,0.76) 0.97 (0.75,1.27) OR GG 1 0.69 (0.47,1.02) 0.60 (0.35,1.05)
GA 0.77 (0.64,0.92) 0.64 (0.53,0.77) 0.64 (0.47,0.86) GT 0.94 (0.63,1.39) 0.69 (0.47,1.03) 0.55 (0.30,1.01)
AA 0.32 (0.22,0.48) 0.78 (0.56,1.08) 0.44 (0.24,0.81) TT 0.19 (0.08,0.43) 0.57 (0.32,1.02) 0.87 (0.28,2.68)
OR1 GG 1 0.64 (0.54,0.76) 0.97 (0.75,1.27) OR1 GG 1 0.69 (0.47,1.02) 0.60 (0.35,1.05)
GA 1 0.83 (0.68,1.02) 0.83 (0.61,1.13) GT 1 0.74 (0.49,1.11) 0.59 (0.32,1.09)
AA 1 2.43 (1.49,3.96) 1.36 (0.66,2.79) TT 1 3.03 (1.19,7.70) 4.67 (1.23,17.8)
OR2 GG 1 1 1 OR2 GG 1 1 1
GA 0.77 (0.64,0.92) 1.00 (0.82,1.22) 0.65 (0.45,0.94) GT 0.94 (0.63,1.39) 1.01 (0.67,1.51) 0.91 (0.44,1.90)
AA 0.32 (0.22,0.48) 1.22 (0.88,1.70) 0.45 (0.23,0.86) TT 0.19 (0.08,0.43) 0.82 (0.46,1.49) 1.45 (0.44,4.79)
Comparison of OR tables between the interaction of rs7522462 and rs11945978 in the WTCCC data with the shared controls (left) and the interaction of the proxy SNPs,
rs296533 and rs2089509 in the IBDGC data (right). The legend to this table is the same as that of Table 3.
doi:10.1371/journal.pgen.1001338.t005
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obvious marginal effect, but they exhibited an excessive interaction
effect. This suggested that some interactions might be missed by
using methods based on single-locus analysis or interaction-based
approaches with non-exhaustive search strategies. On the other
hand, we searched for genetic interactions associated with seven
diseases and observed only one pair of loci that fell within that
extreme situation. Theoretically, because the allele frequency of
genetic loci often varies among different populations, it is relatively
unlikely that marginal effects of the interactions will be obscured in
all populations.
We have noticed that although some loci (or their good proxies)
could not be replicated, the corresponding regions showed
apparent association/interaction signals in the validation data.
The signals were unlikely to be observed by chance given the local
validation p-values. The replication failure for these loci was
unlikely to simply result from insufficient statistical power; because
unlike the replicated interaction for CD, we did not identify any
consistency of the OR values between the datasets for these loci
(data not shown), while the signals were observed. In addition, the
signals were unlikely to be affected by genotyping artifacts, because
multiple loci were considered and the data were initially quality-
controlled. To our knowledge, tens of loci have been identified for
some common diseases, but no interaction between exact loci has
been confirmed in independent populations to date, despite of the
fact that many of the loci are in the same pathway. Based on these
observations, one plausible hypothesis is that the genetic
heterogeneity may affect the consistency of the interactions. We
speculated that many disease-causing interacting loci for common
diseases might reside among rare variants that have large effects,
and these rare variants could vary in frequency between
populations, or they could be on adjacent, but distinct loci
between populations. This could appropriately explain the lack of
consistently observed interactions for common diseases in current
GWASs that used common-variant markers.
The Need of a False Positive Control for Interaction
Analyses
In this study, we found an overwhelming number of false
positives, including artificial associations, in the raw results. The
problem of false positives was more severe in our two-locus
analyses than in the single-locus analyses, because our two-locus
genotype combinations had insufficient sample sizes, which made
them very sensitive to the artificial genotyping errors that were
widely present in GWAS data. In addition, sparse data caused
inaccuracy on asymptotic tests. Therefore, the results of two-locus
analyses require careful examination, and particular attention
must be paid to incredibly small p-values.
In the raw results with linked SNPs, we identified two kinds of
artificial interactions; the batch effect (Figure 3) and the genotype
clustering problem (Figure 4). Note that, although these kinds of
observations were exaggerated by LD, and therefore, were previously
considered as LD effects [8] (rs2532292), they were, in fact, caused by
genotyping artifacts (Figure S5). Thus, interactions with unlinked
SNPs, particularly SNPs with low MAFs, also require careful
examination. In some previous studies, we found probable false
positive results of the same kinds. For example, in two previous works
[12,13], we conducted experimental searches on the WTCCC RA
data without any quality control procedures; all the interactions that
were outside the MHC region contained unqualified SNPs, according
to the WTCCC study. Careful examination showed that many of these
results were SNP pairs with linked SNPs, which were probably artificial
associations of the two kinds mentioned in this study. Only one result
was not affected by unqualified SNPs; but, when this was tested with
quality-controlled samples, we observed a sharp decrease in signifi-
cance. Moreover, a recent study [15] tested a new program on part of
the WTCCC data and reported many interactions; however, almost all
those results were interactions with linked SNPs that showed extremely
significant p-values. We observed a large overlap between those
reported SNPs and the SNPs that were filtered out in this study. In
particular, two of the SNPs that were reported in that study (rs1065705
and rs1420247) were confirmed in this study to be affected by artificial
genotyping errors (Table S1E). We also found that three regions,
PLXNA2, PTPRT,a n dPPM1A that were reported to be ‘‘associated’’
with multiple diseases in the WTCCC data were extremely unlikely to
be true interactions; in particular, we found that the PPM1A region,
with the most significant p-value, was ‘‘associated’’ with all diseases
except BD, and the association was probably a false positive.
Therefore, we suggest that careful false positive control procedures
should be adopted in future GWIBA studies to avoid misleading results
and unnecessary endeavors in subsequent replication analyses.
Limitations
There are a few limitations of this study. First, although GWIBA
permits agnostic searching without the need for prior biological
knowledge, it loses substantial power due to the penalty introduced by
multiple testing corrections for the huge number of potential pair-wise
interactions. Therefore, candidate-gene methods should not be
discarded, because they offer promising, well-powered detection of
interactions based on biological knowledge. For example, a previous
study performed a partial search on genes within certain biological
networks and obtained some significant interactions [18]. Second, the
contingency tables used for fast computing could not incorporate
continuous covariates. However, these might be very important in
some genetic analyses. This problem might be partially addressed by
incorporating the covariates after an initial screen for interactions with
a loose threshold. Third, we had to compromise for the huge
computational issue by using general tests that assumed no specific
geneticmodels; this resulted in decreased power compared to a test that
conforms to a certain specific model. Furthermore, detection of high-
order interactions was restricted to the conditional search, in order to
conserve the computational time. Fourth, two-locus associations should
be interpreted with caution when the single-locus effect of one SNP is
very large; validation analyses should be performed to further confirm
pure interaction effects. Fifth, the non-pseudoautosomal region of the
X chromosome was not included in this analysis due to the imbalanced
proportions of males and females between the case and control groups;
however, many susceptibility loci of common diseases may reside on
the X chromosome. This problem might be addressed by stratifying
the contingency tables with a sex covariate, and then removing the
corresponding female individuals with heterozygote genotypes for the
tested SNPs on the X chromosome. Finally, this method provided
inflated test statistics to detect SNPs with low MAFs, which were
removed from the analysis. The removal may have caused us to miss
low-frequency variants with relatively large effects, and these loci may
be more valuable than common variants with smaller effects [37].
These issues require further studies to be fully addressed. Thus, we do
not unreservedly recommend the approach used in this analysis for
detecting genetic interactions. Rather, we recommend further impro-
vements to this method, and the use of other methods when approp-
riate. Nevertheless, we would like to emphasize that the procedures
described here are important for ensuring the reliability of interactions.
Computational Efficiency of PIAM for Future Large-Scale
GWAS Datasets
We implemented PIAM with a multi-thread/parallel program,
rapid tests for two-locus interactions, optional two-stage strategies
for interaction searching, fast algorithms for collecting contingency
Genome-Wide Interaction-Based Association Analysis
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CPU instruction for new types of CPUs. These components made
PIAM capable of handling very large GWAS datasets that are
anticipated to be commonly available in the future. For example,
the WTCCC2 study will include much larger numbers of SNP
markers and sample sizes for the identification of susceptibility loci
with moderate single-locus effects and interactions. We estimated
that, for a dataset with up to 1,000,000 SNPs and 10,000 samples,
PIAM could complete an exhaustive, two-locus search within 6
days with one computer equipped with a modern quad-core,
3.0 GHz, desktop CPU and 4 G of memory; this speed could be
multiplied with parallel computing on multiple computers.
Figure 3. Batch effect observed for SNPs rs1343295 and rs7543540. (A) For each two-locus genotype combination, a genotype code is shown
in the upper left corner of each cell. NN denotes missing genotypes. The distribution of RA cases (left bar) and controls (right bar) in each genotype
combination is shown with the number of observations indicated above the bars. The samples are mainly distributed on the diagonal of the genotype
combinations, where two SNPs are in LD. Note that many genotype combinations are sparse. An excessive number of cases relative to controls was
observed for the genotype combination TC for rs1343295 and TT for rs7543540 (code 4), which primarily caused the association.
(B) Genotype combination codes (1–10) of samples were plotted against the plate and well numbers of samples in 96-well plates. Codes 1–9 denote
theninenon-missinggenotypesshownin(A).Sampleswithmissinggenotypesweregroupedincode10.Theverticallineseparatescases(left)andcontrols
(right).The59casesofoneparticulargenotypecombination(code4)werenotevenlydistributedamongthewells,butseverelyaggregated.(C)Cluster plot
for RA cases.The coordinates denotethealleleintensities of thefirstSNP in the title (rs1343295)and the 10 colors denotethe10 genotype combinations of
the two SNPs. The genotype clustering of 59 cases (plotted in cyan circles) are ambiguous between heterozygotes and homozygotes for rs1343295, and
genotypes were considered heterozygotes. In fact, the genotypes of these 59 cases should probably be considered homozygotes, and then no association
would exist; however, the batch effect produced this artificial error due to the low-quality genotyping and subsequent artificial clustering.
doi:10.1371/journal.pgen.1001338.g003
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This GWIBA approach can be used routinely, in addition to
single-locus analyses in future genome-wide association studies. It is a
promising approach for the discovery of novel loci with interaction
effects, which may provide important insights into common diseases.
By combining various approaches, we could greatly accelerate the
discovery of the genetic architecture of common diseases.
Materials and Methods
The WTCCC Data
The initial data were obtained from the WTCCC (http://www.
wtccc.org.uk/). This dataset comprised ,2,000 samples each for
seven diseases (BD, CAD, CD, HT, RA, T1D, and T2D). For half
of these samples, there were ,3,000 shared control samples from
Figure 4. Genotype clustering problem observed for rs6578234 and rs7827545. The legend to this figure is the same as that for Figure 3,
except thattheassociateddiseaseisHT,andthepopulationwasdividedintotwocohorts(CandD).Thedescription of(D)is thesameasthatfor(C),except
thatthe1958birthcohortcontrolsampleswereplottedin(D).(A)ThesituationhereissimilartothatshowninFigure3A,withanexcessivenumberofcases
compared to control; in the genotype combination of AG for rs6578234 and CC for rs7827545 (code 4), 109 cases and only 1 control were observed.
However, the batch effect did not occur, because all the plates showed association signals for this combination (B, genotype combination 4). Instead,a
fourth cluster is observed in both case and control groups (C and D); the pattern in the two groups is the same, but the genotypes were assigned different
codes for cases and controls by the genotype calling algorithm CHIAMO. The genotypes of rs7827545 of the 109 HT cases were called homozygotes
(C,indicatedincyan,code4),andthegenotypesin thecontrolswerecalledheterozygotes(D,indicatedinpink,code5).In fact,thegenotypesofrs7827545
of the 109 cases should probably be considered heterozygotes, as in the controls, and no association should exist. We do not know the cause of thefourth
genotype cluster, because the clustering pattern could not be explained by multiple clusters of copy number variation.
doi:10.1371/journal.pgen.1001338.g004
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samples from the National Blood Service (NBS). Genotyping was
performed with the Affymetrix GeneChip Mapping 500K Array
Set. Genotypes were called with the CHIAMO algorithm with the
parameter ‘‘posterior probability less than 0.9’’ set to ‘‘missing’’.
The non-pseudoautosomal SNPs on the X chromosome were not
included, because the general genotypic test was used in PIAM,
and the male/female proportion was imbalanced between the
cases and controls. Quality control for the samples and the SNPs
was performed as described in the WTCCC. In addition, we
excluded SNPs that were significant in the single-locus association
analysis, but showed poor clustering according to the WTCCC.
After trimming, 459,075 SNPs remained for each disease, and the
corresponding data were used as input for the two-locus exhaustive
searches.
Pair-Wise Interaction-Based Association Mapping (PIAM)
We developed a fast, multi-thread/parallel program named
‘‘pair-wise interaction-based association mapping’’ (PIAM, avail-
able at http://www.ihs.ac.cn/xykong/PIAM.zip) to search for
susceptibility SNPs with interaction effects in a set of genome-wide
SNPs. PIAM is based on a two-locus logistic regression model and
the likelihood ratio test (LRT). For the logistic regression model,
the additive effect of a SNP was represented with a variable that
was coded 0, 1, and 2 for homozygote, heterozygote, and the other
homozygote (e.g., AA, AB, BB), respectively. We added another
variable for the heterozygote effect that was coded 1 for hetero-
zygote and 0 otherwise. Therefore, two variables were used for the
general effects of one SNP. The interaction was modeled by the
multiplication of variables between SNPs; thus, four terms were
used for each pair-wise interaction. The interactions can be
interpreted by their deviation from the restricted model without
the interaction terms. The restricted model only considers the
additive effect between the two loci on the log odds ratios, that is,
the multiplicative effect between the two loci on the odds ratios.
The full two-locus logistic model considers all possible effects of the
two loci. Accordingly, the deviation between the two indicates the
significance (or relevance) of the interaction.
A previous study proposed the use of a full, two-locus, logistic
regression model and evaluated its statistical power [10]. However,
when all the SNP pairs were tested with the LRT, and the null
model (with only one intercept term) was compared to the full
model of two SNPs (with an intercept term and eight terms for all
the effects of two SNPs and their interactions), as previously
proposed, there were excessive results associated with the single-
locus effect of a single SNP. Therefore, for practical use, we
modified the previous approach with the following strategy. First, a
single-locus LRT for the general effect of each SNP was
performed. Then, a family-wise-significant, single-locus, p-value
threshold was used to divide the whole set of SNPs into two
subgroups. One subgroup was small and significant (subset A with
n SNPs) and the other subgroup comprised the remainder of SNPs
(subset B with m SNPs). Then, we performed three types of
searches:
(1) The epistatic search. For each of the n(n21)/2 combinations
of SNP pairs within subset A, we used the 4 d.f. LRT of the
logistic regression model comparison (a restricted model
without four interaction terms compared to the full model of
two loci) to test for a pure interaction effect.
(2) The conditional search. For each of the n6m SNP pairs
between subsets A and B, we used a 6 d.f. LRT to test for
marginal and interaction effects of the SNP in subset B that
were conditional on the presence of the SNP in subset A. For
this, a submodel was compared to the full model (the
submodel contained two terms for the SNP in subset A and
one intercept term).
(3) The simultaneous search. For each of the m(m21)/2 SNP
pairs within subset B, we used an 8 d.f. LRT to test for all the
effects of the combination of two SNPs. For this, we compared
the null model to the full model.
For the conditional and simultaneous searches, the LRT
statistics were calculated by the G
2 test with contingency tables
for fast computing. This method was equivalent to the LRT for the
logistic regression models, but it did not estimate the parameters.
In addition, the genotypes were transformed to a set of binary
values to accelerate the collection of contingency tables, as
proposed by a recent study [38]. For the simultaneous search,
we also implemented in PIAM the previously proposed two-stage
strategy [10,39]. The Bonferroni correction was used for N
multiple tests, where N was the total number of tests for all search
situations. Missing genotypes were addressed by removing the
corresponding individual. After the exhaustive two-locus search,
the conditional search was extended to high-order interactions.
For example, conditional on an existing two-locus interaction, the
full two-locus model was compared to a full three-locus model by
adding another locus; this resulted in an 18 d.f. LRT test.
Approximate Statistical Distribution
The huge number of statistics (up to 1610
11) generated in this
study would be extremely computationally demanding to handle
directly. Therefore, to check the overall distributions of the
observed two-locus test statistics, we implemented the approximate
statistical distribution method in PIAM. First, very small,
continuous intervals (e.g., 0.001 in length), were predefined for
the LRT statistics; a maximum value of the statistic was set to be
that with a corresponding p-value equal to 0.01/L, where L was
the total number of comparisons; thus, the last interval was the
maximum value to infinity. During the computation, PIAM
recorded the number of statistics within each small interval, rather
than the exact value of the statistic. When applying the statistics to
the quantile-quantile plot, the statistics were treated as equal to the
lower bound of the corresponding interval; therefore, the error of
the statistic was controlled below 0.001. This method can also be
used to handle p-values transformed by a negative logarithm. The
approximate statistic distributions can further be used in various
multiple test correction approaches. This method can, and should,
be adopted in other GWIBA studies in the future to obtain the
overall statistical distributions, similar to the single-locus analyses.
Additional SNP Quality Control
We found that the initial SNP quality control performed by the
WTCCC was not sufficiently stringent for our interaction analysis.
That control yielded an abundance of extremely significant
interaction results, but these were subsequently identified as false
positives, due to sparse data and/or poor genotyping quality. The
sparse data were introduced by comparing the two-locus
genotypes for the interaction analysis to the single-locus analysis.
These relatively sparse data were more sensitive to genotyping
errors. To avoid that problem, an additional, more stringent SNP
quality control was applied. We removed any SNPs with a missing
data rate that was .2% of the cases or controls, with a MAF,0.1
in the controls, or with a HWE p-value,0.001 in the controls. The
removed SNPs with high missing data rates typically showed poor
genotype clustering; the low frequency SNPs often yielded an
inflated two-locus LRT statistic, due to sparse data (at least one
expected cell count ,5 in the two-locus contingency table for
Genome-Wide Interaction-Based Association Analysis
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both MAFs,0.1); and a deviation from HWE in the control
population was probably due to genotyping errors. After applying
this additional SNP quality control, the test numbers changed for
the Bonferroni correction, due to the removal of SNPs.
Expanded Control Analysis
To improve the detection of true interactions that may not
initially achieve significance within the cases and shared controls,
we applied the expanded control analysis, as performed in the
WTCCC study. The enlarged, ‘‘expanded control’’ was used for
each disease to test pairs of loci with interactions that passed
moderate screening p-value thresholds (50/L in this study, where L
was the total number of two-locus combinations) in the initial
analysis with the cases and shared controls, but did not necessarily
achieve significance (i.e., a Bonferroni corrected P,0.05). In the
expanded control analysis, the final statistical significance was
evaluated. The expanded control for a certain disease was the
combination of the shared control and some other disease cohorts.
For BD, the expanded control group included the shared control
plus the CAD, CD, HT, T1D, and T2D groups. For the three
autoimmune diseases (CD, RA, and T1D), the expanded control
included the shared control plus all other disease cohorts, except
the autoimmune disease cohorts. The same was true for the three
metabolism-related diseases CAD, HT, and T2D. These expand-
ed controls were the same as those used in the WTCCC study.
Note that, associations caused by diseases other than the disease of
interest could be avoided in this expanded control analysis,
because the first stage screening with the shared control required a
low p-value.
The expanded control analysis was not an independent
replication of the initial analysis; therefore, a genome-wide
multiple test correction should also be used when testing the
interactions retained in the initial analysis. For convenience, we
used the same test numbers for correction in the expanded control
analysis as those used in the initial analysis. That is, the two SNP
subsets (subsets A and B) were the same as those in the initial
analysis; therefore, the subset division was not based on the single-
locus p-value of the expanded control. This is similar to the ‘‘joint
analysis’’ strategy [40] of single-locus analyses in GWAS.
However, an additional problem we encountered was the
possibility that some SNPs in subset B might not pass the
5610
27 p-value threshold in the initial analysis, but could pass it in
the expanded control analysis. These SNPs had to be removed to
avoid associations that were caused by a single-locus effect only.
An alternative strategy could be to determine different subsets A
and B for the expanded control analysis. These would be chosen
according to the single-locus p-value threshold of the expanded
control. Then, the corresponding search situation and the
appropriate numbers of multiple tests would be used in the
expanded control analysis.
Result Filtering
First, some interactions detected by tests that incorporate
marginal effects may result from marginal effects alone, without
any pure interaction effects, and we used a strategy similar to
BEAM (the hierarchical significance declaration procedure) [19]
to address this problem. We compared two-locus p-values with
single-locus p-values, as follows. For SNP pairs obtained in the
simultaneous search, we compared the corrected two-locus p-value
to the more significant corrected single-locus p-value of the two
SNPs; for SNP pairs obtained the conditional search, we
compared the corrected two-locus association p-value to the
corrected single-locus p-value of the SNP in subset B; we removed
SNP pairs that had two-locus p-values that were less significant
than the single-locus p-values. The p-values in the expanded
control analysis were used for these comparisons. In addition, we
also removed SNP pairs with any SNPs that did not pass the
5610
27 p-value threshold in the initial analysis, but passed the
threshold in the expanded control analysis.
Second, we examined all SNP pairs that were located within
1 Mb of each other. Two kinds of artificial associations were
found; one was a batch effect and the other was a genotype
clustering problem. The batch effect was severe aggregation of
samples of some individuals with particularly high risk, two-locus
genotypes, in the 96-well plates. The genotype clustering problem
was observed on genotype clustering plots; this manifested as an
ambiguous extra cluster (beyond the normal three clusters) that the
genotype calling algorithm classified differently between the case
and control groups. SNP pairs with either of these problems were
removed from the analyses.
Third, we further checked the regional interaction signals to
avoid artificial associations due to errors in genotyping a given
SNP. Only results with consecutive interaction signals were
retained; i.e., an elevated interaction signal could be observed
on at least two nearby SNPs from both regions. No results were
excluded based on this check in this study.
Validation Analysis of CAD
We used the online analysis results of the German MI Family
Study [2] (http://www.cardiogenics.imbs-luebeck.de/) to test for
allelic effects in order to validate the pair of regions that we had
associated with CAD. We did not have access to the individual-
level genotype data from that study to validate the interaction. The
genotyping platform was the Affymetrix GeneChip Mapping
500K Array Set. The SNPs were quality-controlled; only SNPs
with a trend test P,0.001 were shown on the website. We sear-
ched the website for any SNPs that showed significant single-locus
effects within 50 kb of the loci. Because only SNPs with trend p-
values,0.001 were shown, we could not check the regional signals
or validate the interaction, due to the lack of individual-level
genotypes.
Validation Analysis of CD
The NIDDK IBDGC data (phs000130.v1.p1) [3] was accessed
from the National Center for Biotechnology Information (NCBI)
database of genotypes and phenotypes [41] (dbGaP, http://www.
ncbi.nlm.nih.gov/dbgap/) to validate the interactions for CD. The
dataset was stratified into two populations, the non-Jewish
population stratum, which comprised 513 cases and 515 controls,
and the Jewish population stratum, which comprised 300 cases
and 432 controls. The genotyping platform was the Illumina
HumanHap300 Genotyping BeadChip. The SNPs in the
association result file (pha002847.1.IBD.analysis.tar.gz) were
selected by removing SNPs with call rates ,0.9 in cases or
controls and SNPs with HWE p-values,0.001 in the controls.
Thus, a total of 305,345 SNPs was used as the validation SNP set.
Two subsequent strategies were used for this validation analysis:
the proxy replication strategy and the local validation strategy.
First, proxy replication was implemented; because a different
genotyping platform was used for the IBDGC data compared to
the WTCCC data. SNPs in LD with the original SNPs were
selected for proxy replication. The measurement of LD was based
on the r
2 values from the CEU population data (Phase III release
#2) of the International HapMap Project [26] (HapMap, http://
www.hapmap.org/). The MaCH imputation method [42] was
then used to impute ungenotyped SNPs for validations between
the WTCCC and the IBDGC datasets. Interactions were
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The reference haplotypes for MaCH were obtained from the
HapMap CEU population (Phase III release #2).
Second, ‘‘local validation’’ was used when the locus-based
replication (e.g., proxy replication) failed. In this local validation
method, all SNPs in the validation dataset within 50 kb of the
original loci were tested for allelic effects (by the trend test) or pure
interaction effects (by the 4 d.f. LRT test). This method was based
on the notion that confounding factors might affect the consistency
of the interactions between the original data and the validation
data. The significance was evaluated under the null hypothesis
that none of the SNPs (interactions) in the 100 kb region (pair of
100 kb regions) was associated with the disease. In addition, the
p-values of the SNPs (interactions) should form a uniform
distribution for SNPs that were independent; moreover, the
number of p-values lower than a certain threshold (we used 0.05)
from the total number of p-values should form a binomial
distribution. Therefore, a single-tailed binomial test could be
performed to determine the significance in the numbers of SNPs
with p-values lower than the threshold. However, SNPs were not
independent, due to the LD. Thus, to obtain the empirical
significance for the tests, we randomly sampled 1,000 pairs of
100 kb regions from this validation dataset and calculated the
empirical distribution of the p-values for correction (Table S5). A
significant local validation was interpreted to reject the null
hypothesis, that none of the SNPs or interactions in a certain
region was associated with the disease. However, strictly speaking,
this cannot be interpreted as a successful replication of the original
association or interaction; thus, we used the term ‘‘local
validation’’ instead of ‘‘local replication’’ to avoid confusion.
Validation Analysis of T2D
The GENEVA Diabetes Study data (phs000091.v1.p1) was
accessed from the dbGaP to validate the T2D association results.
The participants in that study were all female. The genotyping
platform was the Affymetrix Genome-Wide Human SNP Array
6.0. Caucasian individuals without missing data on the disease
status were included, SNPs were quality-controlled, and 496,606
genotypes were set to ‘‘missing’’, as initially recommended. After
selection, a total of 1,543 cases and 1,770 controls, with 707,301
SNPs were analyzed. According to the genotyping platforms, the
SNPs in the GENEVA Diabetes Study dataset contained most of
the SNPs in the WTCCC data. Therefore, we could select the
exact SNP combinations in the validation dataset for exact
replication, without the need for the proxy replication described
above. Upon failure of the exact replication, the local validation
method was used with this dataset.
Supporting Information
Figure S1 The distributions of two-locus statistics represented in
quantile-quantile plots. Quantile-quantile plots were generated for
all two-locus LRT statistics in the simultaneous search (A), in the
conditional search (B), and in the epistatic search (C). The LRT
statistics (y coordinates) were sorted and plotted in black circles
against the expected based on the null hypothesis (x coordinates);
the shaded regions show the 95% concentration bands, and the
dashed lines indicate the expected distributions. Statistics that
resulted in p-values,0.01/L are shown in triangles, (L is the total
number of comparisons for the corresponding search situation).
There were no available conditional statistic plots for HT or
epistatic statistic plots for BD and HT. For the simultaneous and
conditional searches (A and B, respectively), the two-locus
statistical distributions for BD, CAD, HT, and T2D fit the
expected quite well; the distributions for the three autoimmune
diseases CD, RA, and T1D showed moderate overdispersion; the
statistical deviations for CD, RA, and T1D started suddenly from
the middle of the dotted lines, and therefore, they did not reflect
general overdispersion. This was due to the many single-locus
associated SNPs for these three diseases, including SNPs in the
MHC region for RA and T1D and multiple associated regions for
CD. Therefore, we applied a strategy similar to BEAM to control
for the excessive single-locus effects in the two-locus associations
(described in Materials and Methods). The statistics for the
epistatic search did not present overdispersion, except for the RA
and T1D data; this was also due to the many significant SNP pairs
within the MHC region. Note that the statistics of artificial
associations identified in this study were not removed from these
plots, which resulted in the extreme deviations in the tails,
particularly in (A).
Found at: doi:10.1371/journal.pgen.1001338.s001 (0.62 MB
PNG)
Figure S2 Regional signal plots of the interaction between
linked SNPs. The format of this figure is the same as that described
in Figure 1.
Found at: doi:10.1371/journal.pgen.1001338.s002 (0.30 MB
PNG)
Figure S3 Cluster plots of the SNPs in Table 1 and one other
pair of linked SNPs. The three genotypes are indicated in red,
green, and blue circles; the black ‘‘+’’ denotes missing genotypes.
Found at: doi:10.1371/journal.pgen.1001338.s003 (1.66 MB JPG)
Figure S4 Linkage disequilibrium plots for the regions in
Table 1. One row represents one pair of regions.
Found at: doi:10.1371/journal.pgen.1001338.s004 (0.97 MB JPG)
Figure S5 Genotype clustering problem of rs2532292. The
legend to this figure is the same as that of Figure 3. (A) The
interaction was yielded by the genotype combination coded as
‘‘4’’, with only a modest effect size; this interaction was detected
because BEAM was sensitive to low frequency variants. (B) The
batch effect did not exist. (C) The cluster plot of rs2532292 in the
cases showed that the four cases with the genotype combination
‘‘4’’ (in cyan) were distributed on the lower edge of the
heterozygote cluster, rather than sporadically distributed. There-
fore, the rs2532292 genotypes for these four cases should be
probably the common homozygotes, and it was the same for the
four controls with the genotype combination ‘‘4’’ (data not shown).
Found at: doi:10.1371/journal.pgen.1001338.s005 (0.74 MB
PNG)
Table S1 Original results. The table file is called ‘‘Table S1.xls’’,
and it is compressed in the zip file. (A) Raw results from PIAM.
This table shows the results generated by PIAM, with the
corresponding disease and the additional SNP quality control
codes in the first and last columns, respectively. The quality
control code ‘‘1’’ denotes an unqualified SNP pair, which includes
at least one SNP that failed the additional quality control; the
quality control code ‘‘0’’ denotes all others. (B) Results excluded
from RA and T1D searches. These results were excluded because
both SNPs were within the MHC region. The format of this table
is the same as that described in (A). (C) Results that passed the
additional SNP quality control in (A) and were tested with the
expanded controls. The format of this table is similar to that
described in (A), with additional columns for information from the
Affymetrix annotations (columns D-O), test numbers (column AR),
interaction LRT statistics and p-values (AW and AX), and
expanded control analysis results (AY-BK). (D) Results that passed
the p-value threshold of Bonferroni corrected P,0.5 in the
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1, a corrected, two-locus p-value that was less significant than the
corrected single-locus p-value of either SNP (for the simultaneous
search) or the SNP in subset B (for the conditional search); 2,
single-locus p-value that exceeded the 5610
27 threshold in the
expanded control analysis; 3, SNP pairs that were located within
1 Mb of each other; 0, results that passed filters 1–3. (E) Results
that failed filter 3. This format of this table is the same as that
described in (D). The results masked in dark grey were false
positives due to the batch effect or genotype clustering problem;
others were not affected. Results highlighted in yellow were the
nearest SNP pairs selected in each associated region. (F) Results
that passed filters 1–3. The format of this table is the same as that
described in (D). Results highlighted in yellow were the SNP pairs
that gave the most significant two-locus p-value within each pair of
associated regions in the initial search.
Found at: doi:10.1371/journal.pgen.1001338.s006 (4.73 MB ZIP)
Table S2 Numbers of multiple tests. The total numbers of SNPs
and the multiple tests used for the Bonferroni correction.
Additional QC: the additional SNP quality control.
Found at: doi:10.1371/journal.pgen.1001338.s007 (0.03 MB
DOC)
Table S3 OR tables for the interaction between linked SNPs.
The legend to this table is the same as that of Table 3.
Found at: doi:10.1371/journal.pgen.1001338.s008 (0.03 MB
DOC)
Table S4 OR tables for the interaction between rs296533 and
rs2089509 with the IBDGC non-Jewish population, Jewish
population, and the imputed WTCCC data. The legend to this
table is the same as that of Table 3.
Found at: doi:10.1371/journal.pgen.1001338.s009 (0.06 MB
DOC)
Table S5 Local validation tests. (A) Detailed results of the local
validation tests. (B) Sampling p-values with the IBDGC non-Jewish
population data. (C) Sampling p-values with the GENEVA T2D
data.
Found at: doi:10.1371/journal.pgen.1001338.s010 (0.21 MB
XLS)
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